In November 2021, a Navy employee driving a small vehicle hauling a cart accidentally struck a drain valve on the overhead ...

Roki Sasaki burst onto the scene in Japan as a 19-year-old in 2021, posting a 1.84 ERA over 16 starts. He bounded onto the ...

According to the report, the Abu Dhabi market is well-positioned for growth, driven by new developers entering the market and ...

A sharp increase in visa cancellations on character grounds has led to a significant spike in the number of people held in ...

Executive recruiters who Axios spoke with are concerned about a lack of succession planning in the communications and ...

Accounting graduates are seeing higher initial pay, and a majority of large firms plan to address workload issues in the next six months. These trends are welcomed, but more is needed, writes Sue ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

A new report suggests OpenAI, Google, and Anthropic have encountered critical issues, including a lack of high-quality ...

Demographics matter. Although I am sending today’s Commentary out from a Dunkin’ near Columbus, Ohio, yesterday I found ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Vislink Technologies, Inc. ( NASDAQ: VISL) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Mickey Miller - Chief Executive Officer Mike Bond - Chief Financial Officer ...